Related Experiment Video
Updated: Oct 16, 2025
10:10
Quantifying Cognitive Decrements Caused by Cranial Radiotherapy
Published on: October 18, 2011
12.8K
Cognitive Assessment Tools Recommended in Geriatric Oncology Guidelines: A Rapid Review
Gina Tuch1, Wee Kheng Soo2,3,4, Ki-Yung Luo5
1Department of Geriatric Medicine, Alfred Health, Melbourne, VIC 3004, Australia.
Current Oncology (Toronto, Ont.)
|October 22, 2021
Summary
This review examines cognitive assessment tools recommended in geriatric oncology guidelines. It details the strengths and limitations of common tools like the Mini-Mental State Examination (MMSE) for cancer care clinicians.
Area of Science:
- Geriatric Oncology
- Neuropsychology
- Clinical Assessment
Background:
- Cognitive impairment significantly impacts cancer care for older adults.
- Accurate identification of cognitive vulnerability is a clinical challenge.
- Geriatric Assessment (GA), including cognition, is recommended by international guidelines.
Purpose of the Study:
- To review cognitive assessment tools frequently recommended by Geriatric Oncology guidelines.
- To appraise the strengths and limitations of these tools for clinical use.
- To provide recommendations for tool selection and implementation in practice.
Main Methods:
- Rapid review of Geriatric Oncology guidelines.
- Focused appraisal of commonly used cognitive assessment tools.
- Evaluation of practical implementation aspects in clinical settings.
Main Results:
- Key tools reviewed include BOMC, CDT, Mini-Cog, MMSE, MoCA, and SPMSQ.
- Analysis of each tool's strengths, limitations, and clinical applicability.
- Discussion of practical considerations for integrating cognitive screening into cancer care.
Conclusions:
- Clinicians must be familiar with validated cognitive assessment tools for geriatric cancer patients.
- Choosing the appropriate tool depends on clinical context and patient needs.
- Considerations beyond initial screening are crucial for comprehensive care.
Keywords:
agedclinical decision-makingcognition/physiologycognitive dysfunction/diagnosisdementia/diagnosisgeriatric assessment/methodsmedical oncology/standardsscreeningMore Related Videos
06:58Highlighting and Reducing the Impact of Negative Aging Stereotypes During Older Adults' Cognitive Testing
Published on: January 24, 2020
7.5K
07:31A Computerized Functional Skills Assessment and Training Program Targeting Technology Based Everyday Functional Skills
Published on: February 13, 2020
7.1K
Related Concept Videos
01:15Drug Dosing: Geriatric Patients
28
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
28
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
36
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
36
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
65
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
65
01:29Nursing Assessment
8.3K
The two sources for collecting information are primary and secondary. After gathering information, interpretation and validation help to complete the data. The purpose of assessment is to establish data with the initial information, to interpret data about the patient's perceived needs and health problems, and to respond to these problems identified.
The nurse collects all aspects of the patient's health in the initial assessment, establishing priorities for ongoing focused assessments...
The nurse collects all aspects of the patient's health in the initial assessment, establishing priorities for ongoing focused assessments...
8.3K
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
21
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
21
01:24Nursing Process for Patient and Caregiver Teaching I: Assessment and Diagnosis
1.9K
The nursing process provides a clinical decision-making framework for patients and families to establish and implement a personalized care plan. Since part of the nurse's duties is to teach patients, the steps of the nursing process are the most effective way to approach instruction. The nursing process and the teaching-learning process are inextricably linked.
It is critical to determine the patient's learning needs during the assessment. Determination of learning needs compounds data...
It is critical to determine the patient's learning needs during the assessment. Determination of learning needs compounds data...
1.9K